Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone injection effects on investor behavior and stress biomarkers
IRCT20251104067879N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of testosterone, hydrocortisone and DehydraTECH-estrogen (2 arms), sponsored by Islamic Azad University. Primary endpoint: Stress hormone levels. Started Dec 2025; status: completed.
02
Drugs
testosteronehydrocortisoneDehydraTECH-estrogen
Beyond the preview
Go deeper on IRCT20251104067879N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251104067879N1.